6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Single Arm, Open Study on vYF in Adults Yellow fever vaccine (live) - Yellow Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 254 | 2025-10-23 | 2026-02-03 |
| Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Yellow fever vaccine (live), YF vaccine (live) - Yellow Fever Immunization | Phase 3 | Completed | Sanofi | 640 | 2025-05-22 | 2026-02-02 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL STAMARIL, SII-YFV - Yellow Fever | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1824 | 2023-05-11 | 2025-05-07 |
| A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Typhoid Vi Polysaccharide Vaccine, Yellow Fever Vaccine, Japanese Encephalitis Vaccine - Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Completed | Novartis | 552 | 2011-11-01 | 2014-03-11 |
| Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Live, attenuated dengue serotype 1, 2, 3, and 4 virus, Yellow fever vaccine, Measles, mumps, and rubella (MMR) vaccine - Dengue, Dengue Hemorrhagic Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 792 | 2011-09-07 | 2022-03-25 |
| The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. Yellow fever vaccination (STAMARIL) - HIV Infection, Yellow Fever | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 71 | 2011-07-01 | 2019-01-18 |
Dengue (1) · Encephalitis, Japanese (1) · Flavivirus Infections (1) · HIV Infections (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Rabies (1) · Severe Dengue (1) · Typhoid Fever (1)
Arbovirus Infections (6) · Flaviviridae Infections (6) · Hemorrhagic Fevers, Viral (6) · Infections (6) · Mosquito-Borne Diseases (6) · RNA Virus Infections (6) · Vector Borne Diseases (6) · Virus Diseases (6) · Flavivirus Infections (5) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Brain Diseases (1) · Central Nervous System Bacterial Infections (1) · Central Nervous System Diseases (1)
Yellow Fever Vaccine (4) · Haemophilus Vaccines (1) · Japanese Encephalitis Vaccines (1) · Measles-Mumps-Rubella Vaccine (1) · MenACWY-CRM vaccine (1) · Rabies Vaccines (1) · Sodium Chloride (1) · Tetanus Toxoid (1) · Vaccines (1) · Vi polysaccharide vaccine, typhoid (1)
Sanofi Pasteur, a Sanofi Company (2) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Novartis (1) · Sanofi (1) · Serum Institute of India Pvt. Ltd. (1)
Colombia (1) · Czechia (1) · France (1) · Germany (1) · Japan (1) · Kenya (1) · Peru (1) · United States (1)
PMID 24873986, PMID 25308927, PMID 30096071
2009 (1), 2014 (1)